跳至主要内容
临床试验/DRKS00015756
DRKS00015756已完成4 期

A PROSPECTIVE COMPARATIVE POST MARKET CLINICAL FOLLOW-UP STUDY TO EVALUATE THE EFFECTIVNESS OF THE HOYA VIVINEX™ PRE-LOADED TORIC INTRAOCULAR LENSES - VIVT-103-MORE

Hoya Medical Singapore PTE. LTD.0 个研究点目标入组 299 人开始时间: 2018年10月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
299

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
22 Years 至 one(—)
性别
All

入选标准

  • 1. Adult subjects with a minimum age of 22 years
  • 2. Planned for first eye cataract extraction or natural lens removal with implantation of a toric IOL
  • 3. Corneal astigmatism in at least one eye between 0.7D to 4.5D (1.0D and 6.0D at IOL plane).
  • 4. Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
  • 5. Clear intraocular media other than cataract in the study eye
  • 6. Expected postoperative BCDVA of 0.2 LogMAR or better in the study eye
  • 7. Expected postoperative pharmacologically dilated pupil diameter of 5.5 mm or greater
  • 8. Signed informed consent

排除标准

  • 1. Requiring an intraocular lens outside the available spherical and cylindrical power range
  • 2. Preoperative previous intraocular and corneal surgery, including corneal refractive surgery, or retinal surgery on the study eyes
  • 3. Traumatic cataract in study eyes
  • 4. Strabismus, Amblyopia or Single Eye status
  • 5. Pupil abnormalities (e.g., non-reactive, fixed pupils, or bnormally shaped pupils)
  • 6. Irregular corneal astigmatism
  • 7. Contact lens wear within 6 months of the preoperative examination for PMMA contact lenses, within 1 month of the preoperative examination for gas permeable lenses, or within 3 weeks of the preoperative examination for extended-wear and daily-wear soft contact lenses in the study eye
  • 8. Presence of corneal pathology affecting topography (e.g. stromal, epithelial or endothelial dystrophy)
  • 9. Acute, chronic, or uncontrolled systemic or ocular disease or illness that would increase the operative risk or confound the outcome of the study (e.g. poorly-controlled diabetes, immunocompromised, connective tissue disease, uncontrolled ocular hypertension, glaucomatous changes in the retina, chronic iritis/uveitis, retinal vessel disease, Sicca syndrome, etc.) or where healing processes are compromised
  • 10. Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects
  • 11. Pregnant, plan to become pregnant, are lactating or have another condition associated with the fluctuation of hormones that could lead to significant refractive changes
  • 12. Concurrent participation in any other clinical trial or if they have participated in any other clinical trial during the last 30 days
  • Intraoperative exclusion criteria:
  • 1. Intraoperative application of parasympatholytica e.g. atropine, tropicamide, etc., for pupil dilation

研究者

发起方
Hoya Medical Singapore PTE. LTD.

相似试验

A PROSPECTIVE COMPARATIVE POST MARKET CLINICAL... | 临床试验